Digitalising Health Data
Greater digitalisation promises improved efficiency, but health data are very sensitive personal data and the population’s mistrust of digitalisation needs to be taken seriously. Our survey explores what the Swiss think and their preferences regarding sensitive personal data collection and sharing.
Seize the digital momentum
Measuring the return from pharmaceutical innovation 2022
The projected return on investment of the global pharmaceutical industry was down significantly from last year; forecast peak sales per asset declined by a quarter. The development process for new drugs must therefore be transformed and could be made much more efficient with digital technologies.
Investment in eye health to prevent sight loss
Investment in eye health to prevent sight loss – presents an in-depth comparison of publicly available data to understand the relationship between investment in eye health and eye outcomes across eight high-income and two low-medium-income countries.
Commercial Operations in Life Sciences
Driving simplification and efficiency across Commercial Operations
Digital transformation of commercial operations has transitioned from a “nice-to-have” enabler to a “must-have” capability, making it critical for Life Science companies to evaluate how digital tools will deliver customer centricity and service innovation across the commercial operations value chain
Forging the links across the value chain
The biopharmaceutical sector is facing digital disruption from multiple sources, the chief among them being artificial intelligence (AI) and cloud. Deloitte predicts that in 2019/2020, all industries will accelerate their use of cloud-based AI software and services, including biopharma companies.
Segmentation and growth factors of the global neuroscience market
Sizing the brain
The report breaks down the Global Neuroscience Market (GNM) across segments and geographies. It provides a comprehensive analysis of available diagnostic and treatment options – as a proxy for market size – to estimate the revenue-based valuation of the GNM until 2026.
Pharma and the connected patient
How digital technology is enabling patient centricity
New research released by the Deloitte UK Centre for Health Solutions explores how digital technology can help pharma embrace patient centricity to remain relevant, profitable, and to deliver better health outcomes.
Time to care
Securing a future for the hospital workforce in Europe
In light of rising demand, staff shortages and lack of time for hands-on-care, is the current hospital workforce model sustainable? New research released by the Deloitte UK Centre for Health Solutions explores the current state of hospital workforces across Europe and their key challenges.
The future awakens
Life Sciences and Health Care Predictions 2022
The year is 2022. The quantified self is alive and well, digital technologies have transformed the culture of health care and new entrants have disrupted delivery models. These are some of our predictions that, if they come true, will shake up the life sciences and health care industry.
Digital health is a broad category of technologies targeting various steps across the patient journey.
Biotech-in-a-box™️ aims to provide a ‘one-stop shop’ for small-to-medium size life sciences companies to de-risk the scaling up of their business by leveraging Deloitte’s portfolio of capabilities.
The Future of Manufacturing Operations
The Future of Manufacturing Operations is Deloitte’s unique approach to help you reshape your business through digital transformation.